glp 1 meds while breastfeeding Navigating GLP-1 and Pregnancy: Insights, Safety, and Postpartum Considerations Frontiers | Effects of GLP-1

A 12-week, randomized, controlled trial with a 4-week randomized withdrawal period to evaluate the efficacy and safety of linaclotide in irritable bowel syndrome with constipation

Activation of AMP kinase enhances sensitivity of muscle glucose transport to insulin

Science 184, 868871

Roth, J.R., J.G

Addition of a dipeptidyl peptidase-4 inhibitor, sitagliptin, to ongoing therapy with the glucagon-like peptide-1 receptor agonist liraglutide: A randomized controlled trial in patients with type 2 diabetes

When Appetite Suppression Plateaus: Adjusting Your GLP-1 Strategy After eight to sixteen weeks on a stable semaglutide dose, some patients notice their appetite returns partially to baselinea phenomenon called tachyphylaxis